{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:21:20Z","timestamp":1783354880106,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.bioorg.2022.106224","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T18:55:04Z","timestamp":1666896904000},"page":"106224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation"],"prefix":"10.1016","volume":"130","author":[{"given":"Guohui","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5800","key":"10.1016\/j.bioorg.2022.106224_b0005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.1132814","article-title":"A century of Alzheimer's disease","volume":"314","author":"Goedert","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2022.106224_b0010","unstructured":"Last accessed, https:\/\/www.alz.co.uk\/research\/world-report-2018. (Accessed 29 December 2018)."},{"issue":"18","key":"10.1016\/j.bioorg.2022.106224_b0015","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1056\/NEJMe2103722","article-title":"Progress with Treatments for Alzheimer's Disease","volume":"384","author":"Levey","year":"2021","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.bioorg.2022.106224_b0020","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejmech.2019.07.021","article-title":"Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease","volume":"180","author":"Sang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2022.106224_b0025","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"issue":"33","key":"10.1016\/j.bioorg.2022.106224_b0030","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.2174\/138161206778792985","article-title":"Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors","volume":"12","author":"Castro","year":"2006","journal-title":"Curr. Pharm. Des"},{"issue":"5022","key":"10.1016\/j.bioorg.2022.106224_b0035","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1678899","article-title":"Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein","volume":"253","author":"Sussman","year":"1991","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bioorg.2022.106224_b0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/jm049156q","article-title":"Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation","volume":"48","author":"Bolognesi","year":"2005","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2022.106224_b0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.abb.2009.12.005","article-title":"Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior","volume":"494","author":"Masson","year":"2010","journal-title":"Arch. Biochem. Biophys"},{"key":"10.1016\/j.bioorg.2022.106224_b0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ejmech.2017.01.042","article-title":"New tacrine-derived AChE\/BuChE inhibitors: Synthesis and biological evaluation of 5-amino-2-phenyl-4H-pyrano[2,3-b]quinoline-3-carboxylates","volume":"128","author":"Eghtedari","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2022.106224_b0055","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2174\/156802612805219950","article-title":"Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival","volume":"12","author":"Naoi","year":"2012","journal-title":"Curr. Top. Med. Chem"},{"issue":"6","key":"10.1016\/j.bioorg.2022.106224_b0060","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1021\/jm4000769","article-title":"Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6'-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors","volume":"56","author":"Pisani","year":"2013","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2022.106224_b0065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00702-012-0948-y","article-title":"Propargylamine-derived multitarget-directed ligands: fighting Alzheimer's disease with monoamine oxidase inhibitors","volume":"120","author":"Bolea","year":"2013","journal-title":"J. Neural. Transm. (Vienna)"},{"issue":"22","key":"10.1016\/j.bioorg.2022.106224_b0070","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1016\/j.bmcl.2017.09.055","article-title":"Design, synthesis and biological evaluation of phthalimide-alkylamine derivatives as balanced multifunctional cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer's disease","volume":"27","author":"Sang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bioorg.2022.106224_b0075","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ejmech.2016.09.041","article-title":"Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"125","author":"Joubert","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2022.106224_b0080","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1021\/acs.jmedchem.6b00562","article-title":"Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents","volume":"59","author":"Pisani","year":"2016","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2022.106224_b0085","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1021\/acs.jmedchem.5b00599","article-title":"Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases","volume":"58","author":"Farina","year":"2015","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2022.106224_b0090","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1021\/jm020120c","article-title":"Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease","volume":"45","author":"Sterling","year":"2002","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2022.106224_b0095","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1021\/jm0340602","article-title":"3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy","volume":"46","author":"Piazzi","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106224_b0100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejmech.2016.03.081","article-title":"(E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors","volume":"117","author":"Desideri","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2022.106224_b0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/1097-0134(20010201)42:2<182::AID-PROT50>3.0.CO;2-1","article-title":"Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs","volume":"42","author":"Bartolucci","year":"2001","journal-title":"Proteins"},{"issue":"10","key":"10.1016\/j.bioorg.2022.106224_b0110","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2174\/1567205018666211208140551","article-title":"Multi-Target Directed Ligands (MTDLs): Promising Coumarin Hybrids for Alzheimer's Disease","volume":"18","author":"Bhatia","year":"2021","journal-title":"Curr. Alzheimer. Res"},{"issue":"1","key":"10.1016\/j.bioorg.2022.106224_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2012-120013","article-title":"From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease","volume":"30","author":"Zheng","year":"2012","journal-title":"J. Alzheimers. Dis"},{"issue":"1","key":"10.1016\/j.bioorg.2022.106224_b0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bmc.2012.10.045","article-title":"Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase","volume":"21","author":"Catto","year":"2013","journal-title":"Bioorg. Med. Chem"},{"key":"10.1016\/j.bioorg.2022.106224_b0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.bioorg.2022.106224_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105129","article-title":"Cyanobiphenyls: Novel H(3) receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer's disease","volume":"114","author":"Gody\u0144","year":"2021","journal-title":"Bioorg. Chem"},{"issue":"2","key":"10.1016\/j.bioorg.2022.106224_b0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00001756-200502080-00006","article-title":"Empirical evidence of neuroprotection by dual cholinesterase inhibition in Alzheimer's disease","volume":"16","author":"Venneri","year":"2005","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.bioorg.2022.106224_b0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","article-title":"Cholinesterase inhibitors: new roles and therapeutic alternatives","volume":"50","author":"Giacobini","year":"2004","journal-title":"Pharmacol. Res"},{"issue":"7","key":"10.1016\/j.bioorg.2022.106224_b0145","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.bmc.2016.02.023","article-title":"Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease","volume":"24","author":"Xie","year":"2016","journal-title":"Bioorg. Med. Chem"},{"key":"10.1016\/j.bioorg.2022.106224_b0150","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejmech.2015.01.058","article-title":"Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties","volume":"93","author":"Xie","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2022.106224_b0155","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/jm201460y","article-title":"New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and \u03b2-amyloid-reducing properties","volume":"55","author":"Fern\u00e1ndez-Bachiller","year":"2012","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2022.106224_b0160","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1021\/jm200716y","article-title":"Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors","volume":"54","author":"Matos","year":"2011","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2022.106224_b0165","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2006.03.190","article-title":"Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity","volume":"344","author":"Y\u00e1\u00f1ez","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.bioorg.2022.106224_b0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejmech.2018.01.003","article-title":"Privileged scaffolds as MAO inhibitors: Retrospect and prospects","volume":"145","author":"Tripathi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2022.106224_b0175","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1021\/jm500729a","article-title":"Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency","volume":"57","author":"Tzvetkov","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106224_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113154","article-title":"Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"213","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106224_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112475","article-title":"Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-\u03b2 aggregation against Alzheimer's disease","volume":"202","author":"Xie","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2022.106224_b0190","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jalz.2009.06.003","article-title":"Alzheimer's disease drug development and the problem of the blood-brain barrier","volume":"5","author":"Pardridge","year":"2009","journal-title":"Alzheimers. Dement"},{"key":"10.1016\/j.bioorg.2022.106224_b0195","article-title":"Recent Development of Bifunctional Small Molecules to Study Metal-Amyloid-\u03b2 Species in Alzheimer's Disease","volume":"2011","author":"Braymer","year":"2010","journal-title":"Int. J. Alzheimers. Dis."},{"issue":"3","key":"10.1016\/j.bioorg.2022.106224_b0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106224_b0205","doi-asserted-by":"crossref","first-page":"2804849","DOI":"10.1155\/2020\/2804849","article-title":"In Vitro and In Vivo Anti-AChE and Antioxidative Effects of Schisandra chinensis Extract: A Potential Candidate for Alzheimer's Disease","volume":"2020","author":"Song","year":"2020","journal-title":"Evid. Based. Complement. Alternat. Med."},{"issue":"8","key":"10.1016\/j.bioorg.2022.106224_b0210","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bioorg.2022.106224_b0215","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejmech.2017.02.039","article-title":"Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"130","author":"Sang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106224_b0220","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2017.07.055","article-title":"Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease","volume":"139","author":"Lan","year":"2017","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822006307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822006307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:34:46Z","timestamp":1758616486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822006307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":44,"alternative-id":["S0045206822006307"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106224","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106224"}}